Completed PHASE3 INTERVENTIONAL 2-arm NCT01025115

Diamel in the Treatment of Metabolic Syndrome

Efficacy of Diamel in the Treatment of Metabolic Syndrome

Sponsor: Catalysis SL

Updated 6 times since 2017 Last updated: Mar 30, 2010 Started: Mar 31, 2009 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Metabolic Syndrome and is currently completed. Catalysis SL leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catalysis SL

Data source: Catalysis SL

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Havana, Cuba